There was no past medical history of note. On clinical examination, a temperature of 39.1°C, blood pressure of 156/80 mmHg, and a pulse of 106/minute were noted. The respiratory rate was recorded at 16 breaths/minute with an oxygen saturation of 95% on room air. The full blood count showed a thrombocytopenia of 81 × 10 9 /L and was otherwise normal; the C-reactive protein was 55 mg/L (reference range up to 5 mg/L). The liver enzymes were slightly elevated with an aspartate aminotransferase of 62 U/L (reference range, 10-50 U/L) and an alanine aminotransferase of 106 U/L (reference range, 10-50 U/L). The bilirubin was 0.5 mg/dL (reference range, <1.2 mg/dL). Rapid diagnostic tests for malaria (Alere BinaxNOW, which detects the Plasmodium falciparum-specific Histidine-rich Protein II and the panmalarial Aldolase) and dengue fever gave negative results. However, a thick blood film showed plasmodia trophozoites at a density of 920/µL. On thin film, the microscopists on duty were unable to differentiate the Plasmodium species in the acute setting. Based on the negative result of the rapid-diagnostic test, a nonfalciparum malaria was suspected. The patient was admitted to the infectious disease ward. Treatment was started with atovaquone/proguanil 250/100 mg 4 tablets daily over 3 days. The patient rapidly recovered and was discharged 4 days after admission. For further parasite differentiation, malaria microscopy was repeated by the head parasitologist. After intense reading of the Giemsa-stained thin blood film, 2 parasite-infected erythrocytes were identified with morphological characteristics compatible with Plasmodium malariae or P knowlesi infection ( Figure 1 ). Subsequently, species-specific polymerase chain reactions (PCRs) for the 5 human plasmodia species confirmed the presence of a monoinfection with P knowlesi [1, 2] .
DISCUSSION
Plasmodium knowlesi was first described in detail in 1932 by Biraj Das Gupta and Robert Knowles in Kalkutta as malaria of macaques [3] . Plasmodium knowlesi gained recognition as the fifth human malaria parasite in 2004, when Singh et al [4] discovered that 58% of microscopically diagnosed malaria patients in the Kapit Division, Sarawak, Borneo, Malaysia were positive for P knowlesi by PCR.
So far, the vast majority of P knowlesi patients have been diagnosed in Sabah and Sarawak, Borneo, Malaysia. Increasing incidences of P knowlesi malaria have been reported from Sabah and Sarawak in the last few years [5] [6] [7] . Plasmodium knowlesi infections have also been identified in Thailand, Vietnam, Singapore, Indonesia, Cambodia, Myanmar, and the Philippines [8, 9] . Travelers returning from Southeast Asia with imported P knowlesi malaria have occasionally been reported from nonendemic countries including the United Kingdome, Australia, Japan, Sweden, and Germany [3, [10] [11] [12] [13] . Vicinity to natural forest areas is the main risk factor for contracting P knowlesi infection. Forests are the natural habitat of the natural hosts of P knowlesi, the long-and pig-tailed macaques [14] . Most patients with documented P knowlesi malaria lived in or at the fringe of forestry areas [3] . Although our patient had not specifically visited a forest or national park, he stayed close to forestry areas on Little Koh Chang and participated in a rafting tour close to Hua Hin as potential exposures. From both areas, the Ranong and Prachuap Khiri Khan provinces, P knowlesi infections in humans have been repeatedly reported [13, [15] [16] [17] [18] . The short time duration between the rafting tour and development of fever (4 days) make an infection at Little Koh Chang more likely, but short incubation periods with a minimum of 3 days have been observed with P knowlesi [19] .
Plasmodium knowlesi presents several diagnostic challenges. Plasmodium knowlesi can be detected by rapid diagnostic tests targeting panmalarial Plasmodium lactate dehydrogenase ( pLDH), Plasmodium vivax-specific pLDH, P falciparumspecific pLDH, or panmalaria Aldolase, but sensitivities are low [14, 20, 21] . In particular, in infections with low parasitemia, rapid diagnostic tests often fail to diagnose an acute P knowlesi malaria, as seen with our patient [20] . Therefore, diagnosis of infection relies primarily on microscopy of blood films, which requires highly trained microscopists. However, even in the hands of an experienced microscopist, P knowlesi can be easily misdiagnosed as Plasmodium malariae due to morphological similarity of the 2 parasite species. Molecular genetic analysis of malaria patients in Sabah, Borneo determined that up to 83% of malaria patients microscopically diagnosed with P malariae malaria were indeed infected with P knowlesi [22] . Polymerase chain reaction is the most reliable method to distinguish P knowlesi from other species, but it is usually not available in an acute setting. This diagnostic challenge has important consequences for patient management. Although P malariae malaria rarely causes complications, being termed "benign quartan malaria", P knowlesi infection can potentially be fatal because the parasite is able to rapidly develop high parasitemia due to its short erythrocytic cycle of only 24 hours. Severe courses of P knowlesi malaria are observed in approximately 10% of hospitalized patients and include respiratory distress syndrome or renal failure [6, 23, 24] .
Several treatment options exist for uncomplicated P knowlesi infection. To date, chloroquine remains widely used for the treatment of confirmed P knowlesi infection [8, 25] . However, due to the increasing chloroquine resistance rates among P falciparum in Asia, chloroquine should only been used when a P falciparum infection or coinfection can be safely excluded [8] . Alternatively, artemisinin-combination drugs are increasingly used as first choice and offer the advantage to cover all malaria species [8, [26] [27] [28] . Furthermore, the first randomized controlled trial for the treatment of P knowlesi malaria, which compared treatment with chloroquine to mefloquine-artesunate, showed a faster parasite clearance when using mefloquineartesunate [29] . Other treatment options for P knowlesi include atovaquone/proguanil, which also treats all malaria species [27] . Severe P knowlesi infection should be treated with parenteral artesunate [8, 28] .
CONCLUSIONS
Our case highlights the need to consider P knowlesi malaria in febrile patients residing in or traveling from Southeast Asia in whom rapid antigen test for malaria is negative and microscopic species definition of plasmodia is inconclusive or a nonfalciparum species is suspected. Polymerase chain reaction assays remain an important tool to reliably identify P knowlesi.
